PedAM
Pediatric Disease Annotations & Medicines
| Disease | collagen disease |
| Phenotype | C1619734|pulmonary arterial hypertension |
| Sentences | 35 |
| PubMedID- 23906950 | pulmonary arterial hypertension associated with connective tissue disease: meta-analysis of clinical trials. |
| PubMedID- 23732415 | Results: the most common connective tissue disease associated with pulmonary arterial hypertension was diffuse scleroderma in 46% of cases. |
| PubMedID- 21676917 | The short-term role of corticosteroid therapy for pulmonary arterial hypertension associated with connective tissue diseases: report of five cases and a literature review. |
| PubMedID- 23334373 | The focus of this review is to increase awareness of pulmonary arterial hypertension (pah) in patients with rheumatic diseases. |
| PubMedID- 25748129 | [management of borderline pulmonary arterial hypertension associated with connective tissue diseases]. |
| PubMedID- 20449950 | Prevalence of anti-endothelial cell antibodies in patients with pulmonary arterial hypertension associated with connective tissue diseases. |
| PubMedID- 22137255 | Methods: forty-eight patients (mean age, 41.3 +/- 11.6 years; 91.7% women) with pulmonary arterial hypertension associated with connective tissue diseases who underwent right-heart catheterization and acute pulmonary vasodilator testing were prospectively recruited. |
| PubMedID- 22205898 | Associated pulmonary arterial hypertension in connective tissue diseases. |
| PubMedID- 22589263 | Comparison of the diagnostic utility of cardiac magnetic resonance imaging, computed tomography, and echocardiography in assessment of suspected pulmonary arterial hypertension in patients with connective tissue disease. |
| PubMedID- 25129118 | [pulmonary arterial hypertension associated with connective tissue diseases]. |
| PubMedID- 25214713 | Effect of th17 and treg axis disorder on outcomes of pulmonary arterial hypertension in connective tissue diseases. |
| PubMedID- 25076994 | Saudi guidelines on the diagnosis and treatment of pulmonary hypertension: pulmonary arterial hypertension associated with connective tissue diseases. |
| PubMedID- 21963571 | pulmonary arterial hypertension associated with connective tissue disease and immunosuppressive therapy. |
| PubMedID- 24822109 | Objective: to investigate the prevalence of anti-endothelial cell antibodies (aeca) in connective tissue diseases (ctd) associated with pulmonary arterial hypertension (pah) and to corroborate the pathologic function of aeca in pah-associated ctds. |
| PubMedID- 21212140 | Frequency of pleural effusions in patients with pulmonary arterial hypertension associated with connective tissue diseases. |
| PubMedID- 25076987 | The second part, however, is more extensive and targets certain groups/diseases of ph, such as connective tissue disease associated with pulmonary arterial hypertension (ctd-apah), hemolytic anemia associated with ph, portopulmonary arterial hypertension, congenital heart diseases (chd)-apah, chronic thromboembolic pulmonary hypertension (cteph), and creating detailed review articles. |
| PubMedID- 23359006 | Objective: to assess the efficacy of epoprostenol treatment in japanese patients with pulmonary arterial hypertension (pah) associated with connective tissue disease (ctd). |
| PubMedID- 21418827 | [the value of brain natriuretic peptide in connective tissue diseases associated with pulmonary arterial hypertension]. |
| PubMedID- 20919946 | Enlarged right-sided dimensions and fibrosis of the right ventricular insertion point on cardiovascular magnetic resonance imaging is seen early in patients with pulmonary arterial hypertension associated with connective tissue disease. |
| PubMedID- 19653056 | Efficacy of bosentan in the treatment of a patient with mixed connective tissue disease complicated by pulmonary arterial hypertension. |
| PubMedID- 22015567 | pulmonary arterial hypertension in connective tissue diseases. |
| PubMedID- 22709477 | Exercise training in pulmonary arterial hypertension associated with connective tissue diseases. |
| PubMedID- 25445949 | connective tissue disease associated with pulmonary arterial hypertension: management of a patient with severe haemodynamic impairment. |
| PubMedID- 26022952 | Patients with pulmonary arterial hypertension associated with connective tissue disease had significantly poorer survival rates compared to other aetiologies (p<0.003).the favourable short-term haemodynamic results and good survival rates, observed in patients receiving both bosentan and sildenafil, supports the use of sequential combination therapy in patients failing on monotherapy in a real-world setting. |
| PubMedID- 23686514 | Rapid progression to pulmonary arterial hypertension crisis associated with mixed connective tissue disease in an 11-year-old girl. |
| PubMedID- 25877137 | [the more particular clinical classification of connective tissue diseases with pulmonary arterial hypertension, the more precise choice of therapy]. |
| PubMedID- 21873802 | Intensive immunosuppressive therapy improves pulmonary hemodynamics and long-term prognosis in patients with pulmonary arterial hypertension associated with connective tissue disease. |
| PubMedID- 22621693 | Treatment of pulmonary arterial hypertension in connective tissue disease. |
| PubMedID- 20160534 | pulmonary arterial hypertension in connective tissue diseases. |
| PubMedID- 26155616 | [clinical and hemodynamic characteristics and possibilities for therapy in patients with severe (functional class iv) pulmonary arterial hypertension associated with diffuse connective tissue diseases]. |
| PubMedID- 25818118 | Associations between sildenafil use and changes in days of hospitalization in a population with pulmonary arterial hypertension associated with connective tissue disease. |
| PubMedID- 20375662 | Assessment of endpoints in pulmonary arterial hypertension associated with connective tissue disease. |
| PubMedID- 22748903 | pulmonary arterial hypertension in connective tissue diseases. |
| PubMedID- 22354598 | No cases of serous retinal or choroidal detachment were observed in either eye in any treatment group at baseline, but both conditions were detected at week 12 in the left eye of one participant with pulmonary arterial hypertension associated with connective tissue disease in the sildenafil 40 mg group (incidence for each=2%). |
| PubMedID- 22720870 | ¶:p < 0.05 in comparison to group 2, pulmonary arterial hypertension associated with connective tissue disease (pah-ctd). |
Page: 1